Literature DB >> 22906805

'A rose is a rose is a rose', but at-risk criteria differ.

Frauke Schultze-Lutter1, Benno G Schimmelmann, Stephan Ruhrmann, Chantal Michel.   

Abstract

BACKGROUND: Over the last 15 years, efforts to detect psychoses early in their prodromal states have greatly progressed; meanwhile, ultra-high risk (UHR) criteria have been the subject of such consensus that parts of them have been proposed for inclusion in DSM-5 in terms of an attenuated psychosis syndrome. However, it is frequently unacknowledged that the definitions and operationalizations of UHR-related at-risk criteria, including the relevant attenuated psychotic symptoms, vary considerably across centers and time and, thus, between prediction studies.
METHODS: These variations in UHR criteria are described and discussed with reference to the rates of transition to psychosis, their prevalence in the general population and the proposed new operationalization of the attenuated psychosis syndrome.
RESULTS: A comparison of samples recruited according to different UHR operationalizations reveals differences in the distribution of UHR criteria and transition rates as well as in the prevalence rates of at-risk criteria in the general population.
CONCLUSION: The evidence base for the introduction of such a new syndrome is weaker than the number of studies using supposedly equal UHR criteria would at first suggest. Thus, studies comparing the effects of different (sub-)criteria not only on transition rates and outcomes but also on other important aspects, such as neurocognitive performance and brain imaging results, are necessary. Meanwhile, the preliminary attenuated psychosis syndrome in DSM-5 should not follow an altogether new definition but, rather, the currently most reliable UHR definition, which must still demonstrate its reliability and validity outside specialized psychiatric services.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22906805     DOI: 10.1159/000339208

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  23 in total

1.  At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction.

Authors:  Paolo Fusar-Poli; Marco Cappucciati; Grazia Rutigliano; Frauke Schultze-Lutter; Ilaria Bonoldi; Stefan Borgwardt; Anita Riecher-Rössler; Jean Addington; Diana Perkins; Scott W Woods; Thomas H McGlashan; Jimmy Lee; Joachim Klosterkötter; Alison R Yung; Philip McGuire
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.

Authors:  Jadon R Webb; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert K Heinssen; Larry J Seidman; Sarah I Tarbox; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Bull       Date:  2015-09       Impact factor: 9.306

3.  Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program.

Authors:  Barbara A Cornblatt; Ricardo E Carrión; Andrea Auther; Danielle McLaughlin; Ruth H Olsen; Majnu John; Christoph U Correll
Journal:  Am J Psychiatry       Date:  2015-06-05       Impact factor: 18.112

Review 4.  Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome.

Authors:  Scott Richard Clark; Klaus Oliver Schubert; Bernhard Theodor Baune
Journal:  J Neural Transm (Vienna)       Date:  2014-10-16       Impact factor: 3.575

5.  Prediction and prevention of psychosis: current progress and future tasks.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Stefanie J Schmidt; Nathalie Kaiser; Joachim Klosterkötter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-26       Impact factor: 5.270

6.  Main Symptomatic Treatment Targets in Suspected and Early Psychosis: New Insights From Network Analysis.

Authors:  Natalia Jimeno; Javier Gomez-Pilar; Jesus Poza; Roberto Hornero; Kai Vogeley; Eva Meisenzahl; Theresa Haidl; Marlene Rosen; Joachim Klosterkötter; Frauke Schultze-Lutter
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

7.  Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups.

Authors:  Scott W Woods; Albert R Powers; Jerome H Taylor; Charlie A Davidson; Jason K Johannesen; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

Review 8.  Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Authors:  Christin Schifani; Sina Hafizi; Tania Da Silva; Jeremy Joseph Watts; M Saad Khan; Romina Mizrahi
Journal:  Int Rev Psychiatry       Date:  2017-12-08

Review 9.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

10.  Duration of unspecific prodromal and clinical high risk states, and early help-seeking in first-admission psychosis patients.

Authors:  Frauke Schultze-Lutter; Jonas Rahman; Stephan Ruhrmann; Chantal Michel; Benno G Schimmelmann; Wolfgang Maier; Joachim Klosterkötter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-09       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.